TP53-mutant AML with ribosomal gene loss exhibits impaired protein translation and sensitivity to HSP90 inhibition

Journal:
Science Advances
Published:
DOI:
10.1126/sciadv.aed7122
Affiliations:
7
Authors:
10
Go to article
Institutions Authors Share
Institute for Research in Immunology and Cancer (IRIC), UdeM, Canada
5.833333
 0.58
University of Montreal (UdeM), Canada
2.333333
 0.23
Princess Margaret Cancer Centre, U of T, Canada
1.000000
 0.10
Hôpital Maisonneuve-Rosemont (HMR), Canada
0.500000
 0.05
CHU Sainte-Justine, Canada
0.333333
 0.03
Interested in Oncology and Carcinogenesis?